Evaluation of thyroid mass

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133.Full text  Abstract

Gharib H, Papini E, Garber JR, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.Full text  Abstract

Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015 Jun;25(6):567-610.Full text  Abstract

Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.Full text  Abstract

Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017 May;14(5):587-95.Full text  Abstract

1. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133.Full text  Abstract

2. Gharib H, Papini E, Garber JR, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.Full text  Abstract

3. Alexander EK, Cibas ES. Diagnosis of thyroid nodules. Lancet Diabetes Endocrinol. 2022 Jul;10(7):533-9. Abstract

4. Sajisevi M, Caulley L, Eskander A, et al. Evaluating the rising incidence of thyroid cancer and thyroid nodule detection modes: a multinational, multi-institutional analysis. JAMA Otolaryngol Head Neck Surg. 2022 Sep 1;148(9):811-8.Full text  Abstract

5. La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015 May 1;136(9):2187-95.Full text  Abstract

6. Kwong N, Medici M, Angell TE, et al. The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk. J Clin Endocrinol Metab. 2015 Dec;100(12):4434-40.Full text  Abstract

7. Ospina NS, Papaleontiou M. Thyroid nodule evaluation and management in older adults: a review of practical considerations for clinical endocrinologists. Endocr Pract. 2021 Mar;27(3):261-8. Abstract

8. MORTENSEN JD, WOOLNER LB, BENNETT WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab. 1955 Oct;15(10):1270-80. Abstract

9. Singh Ospina N, Iñiguez-Ariza NM, Castro MR. Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment. BMJ. 2020 Jan 7;368:l6670. Abstract

10. Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 2023 Apr;11(4):282-98. Abstract

11. Megwalu UC, Moon PK. Thyroid cancer incidence and mortality trends in the United States: 2000-2018. Thyroid. 2022 May;32(5):560-70. Abstract

12. Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015 Jun;25(6):567-610.Full text  Abstract

13. Waguespack SG, Rich TA, Perrier ND, et al. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol. 2011 Aug 23;7(10):596-607. Abstract

14. Bible KC, Kebebew E, Brierley J, et al. 2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2021 Mar;31(3):337-86.Full text  Abstract

15. Zhu Y, Yang S, He X. Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort. J Endocrinol Invest. 2022 Apr;45(4):815-24.Full text  Abstract

16. de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, et al. Cystic thyroid nodules: the dilemma of malignant lesions. Arch Intern Med. 1990 Jul;150(7):1422-7. Abstract

17. Jasim S, Patel KN, Randolph G, et al. American Association of Clinical Endocrinology Disease State clinical review: the clinical utility of minimally invasive interventional procedures in the management of benign and malignant thyroid lesions. Endocr Pract. 2022 Apr;28(4):433-48. Abstract

18. Garber JR, Papini E, Frasoldati A, et al. American Association of Clinical Endocrinology and Associazione Medici Endocrinologi thyroid nodule algorithmic tool. Endocr Pract. 2021 Jul;27(7):649-60.Full text  Abstract

19. Hong HS, Lee JY, Jeong SH. Thyroid disease in children and adolescents. Ultrasonography. 2017 Oct;36(4):289-91.Full text  Abstract

20. Lafontaine N, Learoyd D, Farrel S, et al. Suppurative thyroiditis: Systematic review and clinical guidance. Clin Endocrinol (Oxf). 2021 Aug;95(2):253-264.Full text  Abstract

21. Stasiak M, Lewiński A. New aspects in the pathogenesis and management of subacute thyroiditis. Rev Endocr Metab Disord. 2021 Dec;22(4):1027-39.Full text  Abstract

22. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf). 1995 Jul;43(1):55-68. Abstract

23. Rothman IN, Middleton L, Stack BC Jr, et al. Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism. Eur Arch Otorhinolaryngol. 2011 Oct;268(10):1501-4. Abstract

24. Jiang W, Lu G, Gao D, et al. The relationships between the gut microbiota and its metabolites with thyroid diseases. Front Endocrinol (Lausanne). 2022;13:943408.Full text  Abstract

25. Mikulska AA, Karaźniewicz-Łada M, Filipowicz D, et al. Metabolic characteristics of Hashimoto's thyroiditis patients and the role of microelements and diet in the disease management-an overview. Int J Mol Sci. 2022 Jun 13;23(12).Full text  Abstract

26. Danailova Y, Velikova T, Nikolaev G, et al. Nutritional management of thyroiditis of Hashimoto. Int J Mol Sci. 2022 May 5;23(9).Full text  Abstract

27. Samuels MH. Subacute, silent, and postpartum thyroiditis. Med Clin North Am. 2012 Mar;96(2):223-33. Abstract

28. Shi HH, McHenry CR. Coexistent thyroid nodules in patients with graves' disease: what is the frequency and the risk of malignancy? Am J Surg. 2018 Nov;216(5):980-4. Abstract

29. Staniforth JUL, Erdirimanne S, Eslick GD. Thyroid carcinoma in Graves' disease: a meta-analysis. Int J Surg. 2016 Mar;27:118-25.Full text  Abstract

30. Expert Panel on Neurological Imaging, Zander D, Bunch PM, et al. ACR appropriateness criteria® parathyroid adenoma. J Am Coll Radiol. 2021 Nov;18(11s):S406-22.Full text  Abstract

31. Fingeret AL. Contemporary evaluation and management of parathyroid carcinoma. JCO Oncol Pract. 2021 Jan;17(1):17-21.Full text  Abstract

32. Tang Q, Wang Z. Metastases to the thyroid gland: what can we do? Cancers (Basel). 2022 Jun 19;14(12).Full text  Abstract

33. American College of Radiology. ACR–AIUM–SPR–SRU practice parameter for the performance and interpretation of diagnostic ultrasound of the thyroid and extracranial head and neck. 2022 [internet publication].Full text

34. National Institute for Health and Care Excellence. Thyroid cancer: assessment and management. Dec 2022 [internet publication].Full text

35. Durante C, Hegedüs L, Czarniecka A, et al. 2023 European Thyroid Association clinical practice guidelines for thyroid nodule management. Eur Thyroid J. 2023 Oct 1;12(5).Full text  Abstract

36. Agrawal K, Weaver J, Ngu R, et al. Clinical significance of patterns of incidental thyroid uptake at (18)F-FDG PET/CT. Clin Radiol. 2015 May;70(5):536-43. Abstract

37. Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.Full text  Abstract

38. National Institute for Health and Care Excellence. Thyroid disease: assessment and management. Oct 2023 [internet publication].Full text

39. Hegedüs L. Clinical practice: the thyroid nodule. N Engl J Med. 2004 Oct 21;351(17):1764-71. Abstract

40. Maher DI, Goare S, Forrest E, et al. Routine preoperative laryngoscopy for thyroid surgery is not necessary without risk factors. Thyroid. 2019 Nov;29(11):1646-52. Abstract

41. Pynnonen MA, Gillespie MB, Roman B, et al. Clinical practice guideline: evaluation of the neck mass in adults. Otolaryngol Head Neck Surg. 2017 Sep;157(2 Suppl):S1-30. Abstract

42. Samarasinghe S, Meah F, Singh V, et al. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks. Endocr Pract. 2017 Aug;23(8):989-98. Abstract

43. Li D, Ferguson A, Cervinski MA, et al. AACC guidance document on biotin interference in laboratory tests. J Appl Lab Med. 2020 May 1;5(3):575-87.Full text  Abstract

44. Verbeek HH, de Groot JWB, Sluiter WJ, et al. Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules. Cochrane Database Syst Rev. 2020 Mar 16;3(3):CD010159.Full text  Abstract

45. Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017 May;14(5):587-95.Full text  Abstract

46. Khalid AN, Hollenbeak CS, Quraishi SA, et al. The cost-effectiveness of iodine 131 scintigraphy, ultrasonography, and fine-needle aspiration biopsy in the initial diagnosis of solitary thyroid nodules. Arch Otolaryngol Head Neck Surg. 2006 Mar;132(3):244-50.Full text  Abstract

47. Hales NW, Krempl GA, Medina JE. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol. 2008 Mar-Apr;29(2):113-8. Abstract

48. Piek MW, de Boer JP, Vriens MR, et al. Retrospective analyses of (18)FDG-PET/CT thyroid incidentaloma in adults: incidence, treatment, and outcome in a tertiary cancer referral center. Thyroid. 2021 Nov;31(11):1715-22. Abstract

49. Ayan A, Basaran Y, Kirnap NG, et al. Synchronous thyroid cancer on the edge: incidentalomas of 18F-FDG PET/CT in clinical practice. Niger J Clin Pract. 2021 Jun;24(6):937-42. Abstract

50. Adas M, Adas G, Koc B, et al. Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management. Minerva Endocrinol. 2015 Sep;40(3):169-75. Abstract

51. Boeckmann J, Bartel T, Siegel E, et al. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake? Otolaryngol Head Neck Surg. 2012 Jun;146(6):906-12. Abstract

52. Park JY, Choi W, Hong AR, et al. A comprehensive assessment of the harms of fine-needle aspiration biopsy for thyroid nodules: a systematic review. Endocrinol Metab (Seoul). 2023 Feb;38(1):104-16.Full text  Abstract

53. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007 Sep;36(3):707-35. Abstract

54. Cesur M, Corapcioglu D, Bulut S, et al. Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules. Thyroid. 2006 Jun;16(6):555-61. Abstract

55. Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid. 2009 Nov;19(11):1215-23. Abstract

56. Jo VY, Stelow EB, Dustin SM, et al. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2010 Sep;134(3):450-6. Abstract

57. Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017 Nov;27(11):1341-6.Full text  Abstract

58. Bumpous J, Celestre MD, Pribitkin E, et al. Decision making for diagnosis and management: algorithms from experts for molecular testing. Otolaryngol Clin North Am. 2014 Aug;47(4):609-23. Abstract

59. Alexander EK, Heering JP, Benson CB, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002 Nov;87(11):4924-7.Full text  Abstract

60. Chehade JM, Silverberg AB, Kim J, et al. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr Pract. 2001 Jul-Aug;7(4):237-43. Abstract

61. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal. 2008 Apr 7;5:6.Full text  Abstract

62. British Thyroid Association. Guidelines for the management of thyroid cancer. July 2014 [internet publication].Full text

63. Nishino M, Nikiforova M. Update on molecular testing for cytologically indeterminate thyroid nodules. Arch Pathol Lab Med. 2018 Apr;142(4):446-57.Full text  Abstract

64. Hu MI, Waguespack SG, Dosiou C, et al. Afirma Genomic Sequencing Classifier and Xpression Atlas molecular findings in consecutive Bethesda III-VI thyroid nodules. J Clin Endocrinol Metab. 2021 Jul 13;106(8):2198-207.Full text  Abstract

65. McCoy KL, Jabbour N, Ogilvie JB, et al. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery. 2007 Dec;142(6):837-44. Abstract

66. Kim DH, Kim SW, Basurrah MA, et al. Diagnostic performance of six ultrasound risk stratification systems for thyroid nodules: a systematic review and network meta-analysis. AJR Am J Roentgenol. 2023 Jun;220(6):791-803.Full text  Abstract

67. Peixoto R, Correia Pinto J, Soares V, et al. Primary thyroid lymphoma: A case report and review of the literature. Ann Med Surg (Lond). 2017 Jan;13:29-33.Full text  Abstract

68. Pedersen IB, Knudsen N, Perrild H, et al. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol (Oxf). 2001 Sep;55(3):381-90. Abstract